Home arrow Publication Series arrow LSA Pharma arrow Deals & Alliances arrow Bristol-Myers Squibb Company - Deals and Alliances Report
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Publication Series arrow LSA Pharma arrow Deals & Alliances arrow Bristol-Myers Squibb Company - Deals and Alliances Report

Bristol-Myers Squibb Company - Deals and Alliances Report


Price: $600.00


Executive Summary

The Bristol-Myers Squibb Company Deals & Alliances Report contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category (product, technology, miscellaneous), stage of development, list of partners, deal types (licensing, marketing, etc.), top deals by deal value, partners based on technology with detailed descriptions of the partner firm where disclosed, partners based on product with detailed descriptions of the partner firm where disclosed, partners in other non-product, non-technology deals, with detailed descriptions of the partner firm and terms when available. The report also includes M&A statistics and recent partnering news updates by date.

The Bristol-Myers Squibb Company - Deals and Alliances Report delivers the latest and the most comprehensive intelligence available on Bristol-Myers Squibb Company’s partnerships and M&A activity.

Table of Contents

  • Business Summary
  • Contact Information
  • Company Details
  • No. of Deals by Deal Category
  • List of Partners
  • Deal Types (Table/Graph)
  • No. of Deals by Stage of Development (Table/Graph)
  • Top Deals by Deal Value
  • Partners based on Product
  • Miscellaneous Deals
  • M&A Stats
  • Recent Partnering Updates

Pages: 68


Life Science Analytics, Inc. (LSA), is a biomedical data company that provides comprehensive pipeline and financial information on more than 8,000 biomedical companies worldwide. Our data and research products serve executives in the pharmaceutical, biotech, and financial industries. LSA products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes.

Life Science Analytics reports are based on the most comprehensive database of private and public biomedical companies available.

Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. LSA distills and systematizes pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide it’s clients with the most comprehensive and up-to-date information available.

View other Deals and Alliances Reports from LSA

Other Similar Company Reports

CompetitorFinancialProduct Pipeline



:

 


Download Fax Order Form/ PO Form

Request free sample pages from this product















Featured Products


Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market
$3 350.00
$2 680.00
You Save: 20.00%

Cancer Drug Resistance 2008
$2 995.00
$2 396.00
You Save: 20.00%

Future Focus: Gastrointestinal Stromal Tumor
$26 250.00
$19 687.50
You Save: 25.00%

Future Focus: Myelodysplastic Syndrome
$26 250.00
$19 687.50
You Save: 25.00%

Search Products

Advanced Search

Your Cart

Show Cart
Your Cart is currently empty.
Advertisement
 
 
 
© 2008 BioMarket Group